Anti-cancer drugs: molecular mechanisms of action

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Genetic mutations are the root cause of all cancers.
• Alterations in key signaling pathway proteins, notably Ras and p53, are central to malignant transformations.
• Mutations in Ras and p53 are implicated in a majority of human cancers.

Purpose of the Study:

• To elucidate the consequences of transformed Ras and p53 proteins and their biochemical interlinks in intracellular signaling pathways.
• To identify intervention points within these pathways for cancer control.
• To review current pharmacological strategies for combating cancer by targeting these pathways.

Main Methods:

• Review of scientific literature on Ras and p53 mutations and their roles in cancer.
• Analysis of intracellular signaling pathways influenced by these proteins.
• Examination of existing and potential pharmacological interventions.

Main Results:

• Ras proteins act as critical switches regulating cell proliferation, differentiation, and apoptosis.
• p53, the "genome guardian," is vital for suppressing cell proliferation.
• Mutated Ras and p53 significantly drive malignant transformation by disrupting normal cellular processes.

Conclusions:

• Comprehending the impact of Ras and p53 alterations on intracellular signaling is essential for understanding cancer.
• Targeting these pathways offers significant potential for developing novel anti-cancer drugs.
• Further research into these biochemical interlinks can lead to more effective cancer treatments.